Australian Formula Maker Wins Permanent US Market Authorization for Three Products Amid Fresh Infant Safety Scrutiny
Bubs Australia says the FDA granted permanent authorization for three infant formulas, ending a temporary pathway created during the 2022 shortage.
Medical Daily ·